The available evidence supports that the contribution of RPN11/PSMD14 to ovarian cancer aggressiveness may derive from the cooperation among different mechanism, because it has been reported to decrease the enzymatic activity of pyruvate kinase M2 (PKM2). The gene discussed is PKM; the disease is ovarian cancer.